Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease

Clinical trial NCT01410890 · COMPLETED

Trial details

NCT number: NCT01410890
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pompe Disease Glycogen Storage Disease Type II (GSD II)

Start date: 2014-11-03
Primary completion: 2020-11-20
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.